Impaired factor XIIa-dependent activation of fibrinolysis in treated antiphospholipid syndrome gestations developing late-pregnancy complications

American Journal of Obstetrics and Gynecology

Volumn 194, Issue 2, 2006, Pages 457-465

  Carmona, Francisco ^a   Lázaro, Isabel ^a   Reverter, Juan C ^a   Tàssies, Dolors ^a   Font, Josep ^a   Cervera, Ricard ^a   Balasch, Juan ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Antiphospholipid syndrome; Factor XII activity; Fibrinolysis; Hemostasis; Pregnancy complications

Indexed keywords

ALPHA 2 ANTIPLASMIN; BLOOD CLOTTING FACTOR 12A; BLOOD CLOTTING FACTOR 7A; PHOSPHOLIPID ANTIBODY; PLASMIN; PROTHROMBIN; UROKINASE;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLOOD CLOTTING FACTOR 12 DEFICIENCY; CONTROLLED STUDY; FEMALE; FIBRINOLYSIS; FRIEDMAN TEST; HUMAN; MAJOR CLINICAL STUDY; PREECLAMPSIA; PREGNANCY COMPLICATION; PRENATAL GROWTH; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANK SUM TEST; SPONTANEOUS ABORTION; THIRD TRIMESTER PREGNANCY;

ADULT; ANTIPHOSPHOLIPID SYNDROME; BLOOD COAGULATION FACTORS; FACTOR XIIA; FEMALE; FETAL GROWTH RETARDATION; FIBRINOLYSIS; HUMANS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, SECOND; PROSPECTIVE STUDIES;

EID: 31844447748     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2005.08.059     Document Type: Article

References (35)

1. G.R.V. Hughes The antiphospholipid syndrome: ten years on Lancet 342 1993 341 343
2. J. Balasch, F. Carmona, M. Creus, J. Font, and R. Cervera Management of reproductive failure in the antiphospholipid syndrome R.A. Asherson R. Cervera J.-C. Piette Y. Shoenfeld The antiphospholipid syndrome II: autoimmune thrombosis 2002 Elsevier Science Amsterdam 375 394
3. F. Carmona, J. Font, M. Azulay, M. Creus, F. Fábregues, and R. Cervera Risk factors associated with fetal losses in treated antiphospholipid syndrome pregnancies: a multivariate analysis Am J Reprod Immunol 46 2001 274 279
4. D.W. Branch, R. Silver, J. Blackwell, J. Reading, and J.R. Scott Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience Obstet Gynecol 80 1992 614 620
5. D.W. Branch Thoughts on the mechanism of pregnancy loss associated with the antiphospholipid syndrome Lupus 3 1994 275 280
6. M. Backos, R. Rai, N. Baxter, I.T. Chilcott, H. Cohen, and L. Regan Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin Br J Obstet Gynaecol 106 1999 102 107
7. W. Kutteh, N.S. Rote, and R. Silver Antiphospholipid antibodies and reproduction: the antiphospholipid antibody syndrome Am J Reprod Immunol 41 1999 133 152
8. S.L. Field, T.A. Brighton, H.P. McNeil, and C.N. Chestgerman Recent insights into antiphospholipid antibody-mediated thrombosis Baillieres Clin Hematol 12 1999 407 422
9. G. Espinosa, R. Cervera, J. Font, and Y. Shoenfeld Antiphospholipid syndrome: pathogenic mechanisms Autoimmun Rev 2 2003 86 93
10. T. Sugi, and T. Makino Plasma contact system, kallikrein-kinin system and antiphospholipid-protein antibodies in thrombosis and pregnancy J Reprod Immunol 47 2000 169 184
11. T. Sugi, and T. Makino Autoantibodies to contact proteins in patients with recurrent pregnancy losses J Reprod Immunol 53 2002 269 277
12. T. Sugi, and T. Makino Antiphospholipid antibodies and kininogens in pathologic pregnancies: a review Am J Reprod Immunol 47 2002 283 288
13. S. Donohoe, S. Quenby, I. Mackie, G. Panal, R. Farquharson, and R. Malia Fluctuations in levels of antiphospholipid antibodies and increased coagulation activation markers in normal and heparin-treated antiphospholipid syndrome pregnancies Lupus 11 2002 11 20
14. F. Zito, G.D.O. Lowe, A. Rumley, A.D. McMahon, and S.E. Humphries Association of the factor XII 46C > T polymorphism with risk of coronary heart disease (CHD) in the WOSCOPS study Atherosclerosis 165 2002 153 158
15. C. Craven, and K. Ward Embryo, fetus, and placenta: normal and abnormal J.R. Scott P.J. Di Saia C.B. Hammond W.N. Spellacy Danfort's obstetrics and gynecology 8th ed. 1999 Lippincott, Williams & Wilkins Philadelphia 29 45
16. W.A. Wilson, A.E. Gharavi, T. Koike, M.D. Lockshin, D.W. Branch, and J.C. Piette International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome Arthritis Rheum 42 1999 1309 1311
17. American College of Obstetrics and Gynecology ACOG practice bulletin. Perinatal care at the threshold of viability. No. 38, September 2002 Int J Gynaecol Obstet 79 2002 181 188
18. J.S. Moldenhauer, and B.M. Sibai Hypertensive disorders of pregnancy J.R. Scott R.S. Gibbs B.Y. Karlan A.F. Haney Danforth's obstetrics and gynecology 9th ed. 2003 Lippincott, Williams & Wilkins Philadelphia 257 271
19. C.A. Nimrod, and A. Gruslin Biology of normal and deviant fetal growth A. Reece J.C. Hobbind Medicine of the fetus and mother 2nd ed. 1999 Lippincott-Raven Publishers Philadelphia 267 278
20. A.G. Witlin, and B. Sibai Hypertensive diseases in pregnancy A. Reece J.C. Hobbind Medicine of the fetus and mother 2nd ed. 1999 Lippincott-Raven Publishers Philadelphia 997 1020
21. E. Amon Preterm labor A. Reece J.C. Hobbind Medicine of the fetus and mother 2nd ed. 1999 Lippincott-Raven Publishers Philadelphia 1529 1579
22. C. Bamberg, and K.D. Kalache Prenatal diagnosis of fetal growth restriction Semin Fetal Neonatal Med 9 2004 387 394
23. J.T. Brandt, D.A. Triplett, B. Alving, and I. Scharrer Criteria the diagnosis of lupus anticoagulant: an update. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH Thromb Haemost 74 1995 1185 1190
24. J. Kienast, J. Kienast, T. Padro, M. Steins, C.X. Li, and K.W. Schmid Relation of urokinase-type plasminogen activator expression to presence and severity of atherosclerotic lesions in human coronary arteries Thromb Haemost 79 1998 579 586
25. K.A. Bremme Haemostatic changes in pregnancy Best Pract Res Clin Haematol 16 2003 153 168
26. M. Hellgren Hemostasis during normal pregnancy and puerperium Sem Thromb Hemost 29 2003 125 130
27. Y. Cadroy, H. Grandjean, J. Pichon, R. Desprats, A. Berrebi, and A. Fournié Evaluation of six markers of haemostatic system in normal pregnancy and pregnancy complicated by hypertension of pre-eclampsia Br J Obstet Gynaecol 100 1993 416 420
28. A. Halligan, J. Bonnar, B. Sheppard, M. Darling, and J. Walshe Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre-eclampsia Br J Obstet Gynaecol 101 1994 488 492
29. P. de Moerloose, J. Amiral, A.M. Vissac, and G. Reber Longitudinal study on activated factors XII and VII levels during normal pregnancy Br J Haematol 100 1998 40 44
30. A. Elias, S. Bonfils, M. Daoud-Elias, B. Gauthier, P. Sie, and H. Boccalon Influence of anticoagulants upon prothrombin fragment 1+2, thrombin-antithrombin III complex and D-dimer levels in patients affected by proximal deep vein thrombosis Thromb Haemost 69 1993 302 305
31. E.A. Braat, G. Dooijewaard, and D.C. Rijken Fibrinolytic properties of activated FXII Eur J Biochem 263 1999 904 911
32. J.E. Salmon, G. Girardi, and V.M. Holers Activation of complement mediates antiphospholipid antibody-induced pregnancy loss Lupus 12 2003 535 538
33. V.M. Holers, G. Girardi, L. Mo, J.M. Guthridge, H. Molina, and S.S. Pierangeli Complement C3 activation is required for antiphospholipid antibody-induced fetal loss J Exp Med 195 2002 211 220
34. S.S. Pierangeli, G. Girardi, M. Vega-Ostertag, X. Liu, R.G. Espinola, and J. Salmon Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia Arthritis Rheum 52 2005 2120 2124
35. G. Girardi, P. Redecha, and J.E. Salmon Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation Nat Med 10 2004 1222 1226